Trial Update November 10, 2026

Linaclotide Bowel-Prep Trial Terminated, ClinicalTrials.gov Shows

A clinical trial evaluating linaclotide for colonoscopy bowel preparation was marked as terminated, according to a ClinicalTrials.gov record dated November 10, 2026. The study, titled "Linaclotide for Colonoscopy Bowel Prep," was registered as NCT06692673 and listed under combined Phase 1 and Phase 2 status. The registry entry shows the trial's current status as terminated as of the record date. No results, efficacy data, or safety findings were included in this update. The available information does not specify the reason for termination. Linaclotide is an approved compound used in other indications, and this trial explored its potential use in a bowel preparation context ahead of colonoscopy procedures. Readers should note that a termination listing reflects the trial's administrative status only and does not by itself indicate findings about safety or effectiveness. Further details, if released, would typically appear as updates to the same ClinicalTrials.gov registration. For additional context on linaclotide, including its approved uses and general background, readers can consult the compound overview.

See the full linaclotide overview

Source: https://clinicaltrials.gov/study/NCT06692673